Showing results (271-280 of 295) with videos related to
Sort By:
Pageof 30
JAMA Network Open|November 27, 2024
Patient, Caregiver, and Clinician Perspectives on the Time Burdens of Cancer CareArjun Gupta, Whitney V Johnson, Nicole L Henderson, et al.Frontiers in Public Health|December 30, 2021
Impact of the COVID-19 Pandemic on Cancer Researchers in 2020: A Qualitative Study of Events to Inform Mitigation StrategiesLouis Fox, Katharina Beyer, Elke Rammant, et al.JCO Global Oncology|July 19, 2022
Cancer Medicines: What Is Essential and Affordable in India?Manju Sengar, Adam Fundytus, Wilma Hopman, et al.JCO Global Oncology|July 24, 2020
State of Cancer Control in Rwanda: Past, Present, and Future OpportunitiesFidel Rubagumya, Ainhoa Costas-Chavarri, Achille Manirakiza, et al.JCO Global Oncology|June 24, 2022
Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional SurveyAvram E Denburg, Adam Fundytus, Muhammad Saghir Khan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2025
Novel Systemic Anticancer Treatments and Health Services Use at the End of Life Among Adults With CancerJavaid Iqbal, Rahim Moineddin, Kieran L Quinn, et al.Journal of Cancer Policy|January 9, 2026
Accelerating cancer treatment optimisation: A multistakeholder roadmap from the Cancer Medicines ForumDenis Lacombe, Fábio Cardoso Borges, Ana E Amariutei, et al.European Journal of Cancer (Oxford, England : 1990)|April 8, 2023
Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of CancerRobbe Saesen, Mieke Van Hemelrijck, Jan Bogaerts, et al.British Journal of Cancer|September 4, 2025
Recommendations for studying the association of the cancer diagnosis to treatment interval with overall survival: a modified Delphi processMatthew Jalink, Will D King, Benjamin O Anderson, et al.European Journal of Cancer (Oxford, England : 1990)|May 14, 2022
Effects of metformin and statins on outcomes in men with castration-resistant metastatic prostate cancer: Secondary analysis of COU-AA-301 and COU-AA-302Brooke E Wilson, Andrew J Armstrong, Johann de Bono, et al.Pageof 30